No abstract available
Keywords:
Atorvastatin; Bisphosphonates; Osteonecrosis; Wnt signaling; Zoledronic acid.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Animals
-
Atorvastatin / adverse effects
-
Bisphosphonate-Associated Osteonecrosis of the Jaw* / drug therapy
-
Bone Density Conservation Agents* / adverse effects
-
Diphosphonates / pharmacology
-
Jaw
-
Osteonecrosis* / chemically induced
-
Osteonecrosis* / drug therapy
-
Rats
-
Zoledronic Acid / adverse effects
Substances
-
Bone Density Conservation Agents
-
Diphosphonates
-
Zoledronic Acid
-
Atorvastatin